BioSpace News Archive

Oncimmune: Launch of ‘Finger Stick’ Sample Collection for EarlyCDT-Lung

Simplified blood sample collection procedure introduces ease of use and quicker results.

November 9, 2017
·
3 min read
FDA

FDA Approves Seattle Genetics’ Adcetris to Treat Disfiguring Blood Cancer

The approval is based on data from the phase 3 ALCANZA trial and two phase 2 investigator-sponsored trials.

November 9, 2017
·
16 min read
Business

Dr. Charles J. Fisher, Jr. Joins Aethlon Medical’s Board of Directors

Dr. Fisher qualifies as an independent director under the Nasdaq Rules, and his appointment fills an open Board seat.

November 9, 2017
·
5 min read
Business

Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results

Top-line results from MGL-3196 Phase 2 clinical trials in NASH and HeFH expected in late 2017 and early 2018, respectively.

November 9, 2017
·
9 min read
Drug Development

Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)

These data will be presented at 4:45 P.M. E.T. on Saturday, November 11th.

November 9, 2017
·
8 min read
BioMidwest

New Post-Hoc Analysis Evaluating Deep Remission With Entyvio (vedolizumab) in Patients With Moderately to Severely Active Ulcerative Colitis Recognized as Poster of Distinction at AIBD 2017 Annual Conference

The poster was selected as a “Poster of Distinction” for presentation at the 2017 AIBD annual conference, held in Orlando, Florida, November 9-11.

November 9, 2017
·
10 min read
Andor Adds Dragonfly 200 to Its Highly Successful High-Speed Confocal Imaging Platform

Dragonfly integrates Andor’s industry-leading cameras, with patented illumination technologies and optimized optical design.

November 9, 2017
·
2 min read
Business

CASMED Reports Third-Quarter 2017 Financial Results

Net sales from continuing operations for the third quarter of 2017 were $4.5 million, compared with $5.0 million for the prior-year period.

November 9, 2017
·
10 min read
Pharm Country

ADMA Biologics Announces Pricing of Follow-On Offering

In addition, ADMA has granted the underwriters a 30-day option to purchase up to approximately 2.5 million additional shares of common stock to cover over-allotments, if any.

November 9, 2017
·
10 min read
Drug Development

Abeona Enrolls First Subject in Spain in Ongoing Phase I/II Clinical Trial in MPS IIIA

Abeona has established a local subsidiary to manage clinical trial and regulatory development efforts in Europe.

November 9, 2017
·
4 min read